Takeda Pharmaceutical Company Limited (TKPHF) Management on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/04/20
LogicBio Therapeutics Announces Collaboration with Takeda to Develop New Genome Editing Candidate LB-301 for the Treatment of Crigler-Najjar SyndromeGlobeNewsWire • 01/10/20
Takeda Pharmaceutical Co. Ltd (TAK) CEO Christophe Weber on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/03/19
Takeda Pharmaceutical Co. Ltd (TKPHF) CEO Christophe Weber on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/01/19
Kamada Announces Extension of GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] Supply and Distribution Agreement with Takeda Through 2021 and Expected Transition of GLASSIA Manufacturing to TakedaGlobeNewsWire • 09/03/19
Takeda Pharmaceutical Co., Ltd. (TKPHF) CEO Christophe Weber on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/01/19